Stensen duct dilation: Case series of minimally invasive treatment

Oral Surgery, Oral Medicine, Oral Pathol.. - 1w ago Preview

 
 
• AUTO POST
 
• SAVE TO EVERNOTE

Publication date: June 2019

Source: Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, Volume 127, Issue 6

Author(s): Marc-Kevin Le Roux, Nicolas Graillon, Mehdi Hadj-Saïd, Ugo Scemama, Jean-Christophe Lutz, Cyrille Chossegros

Stensen's duct dilation is a rare condition characterized by a global or partial idiopathic dilation of the Stensen duct. Affected individuals usually show either aesthetically compromised features, such as a tubular-shaped swelling in the cheek, or with mildly painful inflammatory episodes. Three women between ages 61 and 67 years were diagnosed with Stensen duct dilation after sialo–magnetic resonance imaging (MRI). They were treated with botulinum toxin A (BTX-A). Our preliminary results suggest that BTX-A was efficient as a suspensive treatment. BTX-A should remain a first-line treatment of the early silent symptoms of Stensen duct dilation, such as swelling and aesthetic issues. The use of BTX-A avoids more serious procedures and further complications.